Publications and documents

of the GPFC

Bandeau

Publications

First child-friendly formulation of Amlodipine is now available for Canadien children

We are very proud ton announce that one of the medication identified on its priority list is now accessible to pediatric patients. We invite you to read the full press release

CPFC Welcomes the announcement of Miniter Petitas TAYLOR

July 2019 - We welcomes the new measures announced by the Canadian government to facilitate access to medications in forms that are adapted to the needs of children

Another success for the GPFC of the CHU Sainte-Justine

Two formulations of Levetiracetam are now available in Canada indicated for use in children

Good news: Caffeine Citrate Oral/IV Dolution (Peyona™) and Glycopyrrolate oral solution (Cuvposa™)

The Pediatric Formulations Centre of the CHU Sainte-Justine welcomes the announcement of Minister Petitpas Taylor

Launching the Goodman Pediatric Formulations Center

Scientific publications

Topical nitroglycerin ointment as salvage therapy for peripheral tissue ischemia in newborns: a systematic review
The GPFC of the CHU Sainte-Justine recently participated in this important paper about the use of topical nitroglycerin in pediatrics and published in the CMAJ Open.

Annual Reports

Annual report 2018-2020

Annual report 2017-2018

Final report of the workshop

Improving access to pediatric formulations in Canada

Documents

Final report of the workshop: Improving access to pediatric formulations in Canada

Advocacy letter for the year 2019

Advocacy letters for the year 2018

Position statement on improving pediatric medicines

Posters and presentations

Presentation at the Pediatric Academic Societies virtual annual conference
“Drug Prescriptions Requiring Compounding at a Canadian University Affiliated Pediatric Hospital: A Cross-Sectional Study” (n. 908) | May 2021

Presentation at the Canadian Society of Pharmaceutical Sciences

"Increasing Access to Safe and Effective Pediatric Formulations" | November 2020

Abstract poster for the European Paediatric Formulation Initiative

"Age-Appropriate Formulations at Any Cost? A Canadian Case Example" | August 2020

Abstract poster for the European Paediatric Formulation Initiative

"An Urgent Need for Canada to Have Access to Commercial Pediatric Formulations: Children Deserve the Same Standards as Adults" | September 2019

Presentation at the Pediatric Chairs of Canada

"Advancing Pediatric Formulations" | February 2019

Presentation at the National Cannabinoid Clinical Trials Conference Call

"Considerations for the Pediatric Formulations of Cannabis" | February 2019

Presentation at the Bioeurope Conference, Copenhague

"The Goodman Pediatric Formulations Centre" | 2018

Abstract poster for the American Society for Clinical Pharmacology & Therapeutics

"A Pan-Canadian Study On The Compounded Medicines Most In Need Of Commercialized Oral Pediatric Formulations" | 2018

Web links

Pharmacare in Canada: The Paediatric Perspective (september 2019)
Position Statement on Canadian Drug Insurance and the Pediatric Perspective
Improving paediatric medications: A prescription for canadian children and youth (august 2019)
Position statement on improving pediatric medicines

About this page
Updated on 5/26/2021
Created on 5/28/2020
Alert or send a suggestion